+ All Categories
Home > Education > CI: Non est miraculum - Dr. Dr. h. c. Monika Lehnhardt

CI: Non est miraculum - Dr. Dr. h. c. Monika Lehnhardt

Date post: 26-Jun-2015
Category:
Upload: monika-lehnhardt
View: 348 times
Download: 1 times
Share this document with a friend
Popular Tags:
24
Cochlear Implant – non est miraculum Dr. Monika Lehnhardt Cernobbio, May 29, 2004
Transcript
Page 1: CI: Non est miraculum - Dr. Dr. h. c. Monika Lehnhardt

Cochlear Implant –non est miraculum

Dr. Monika LehnhardtCernobbio, May 29, 2004

Page 2: CI: Non est miraculum - Dr. Dr. h. c. Monika Lehnhardt

The first hearing impression

Page 3: CI: Non est miraculum - Dr. Dr. h. c. Monika Lehnhardt

Nucleus® system 3

Nucleus ® 24 Contour Advance™

ESPrit™ 3G

Page 4: CI: Non est miraculum - Dr. Dr. h. c. Monika Lehnhardt

Implant development – the state of the art

Page 5: CI: Non est miraculum - Dr. Dr. h. c. Monika Lehnhardt

Speech Processor development –the state of the art

Page 6: CI: Non est miraculum - Dr. Dr. h. c. Monika Lehnhardt

Failures

Page 7: CI: Non est miraculum - Dr. Dr. h. c. Monika Lehnhardt

Hard failure vs. soft failure

CI24M after strong impact

Hard failure• A device requires explantation due to design weakness,

manufacturing fault, external impact or electrode failure with loss of clinical benefit.

Soft failure• Deviation from the specification with no loss of clinical

benefit. Resolved via programming.

Page 8: CI: Non est miraculum - Dr. Dr. h. c. Monika Lehnhardt

The Cochlear Reporting Standard•“Any explantation which is assessed to be required because of loss of clinical benefit due to the device not meeting its specifications.”

• Outright Device failures e.g. IC• Failure due to external impact• Failure due to fatigue caused by placement error• Failure of array resulting in loss of clinical benefit

Cochlear implant manufacturers are not obliged by any international certification standards to report failures caused by external agents, such as impact to the head. However, Cochlear believes that since the implant is in a part of the body that is vulnerable to impact,especially for children, there is an ethical responsibility to report all failures resulting from impact with an external agent

Page 9: CI: Non est miraculum - Dr. Dr. h. c. Monika Lehnhardt

Cumulative Survival Percentage (CPS): What does it mean?

020406080

100

1 2 3 4

• CSP shows the percentage of devices which have functioned at a given length of time after implantation.

• Ensures that clinicians can confidently counsel patients on the risk of technical failure in real-life circumstances.

• Cochlear exceeds the requirements of ISO 5841/2

Page 10: CI: Non est miraculum - Dr. Dr. h. c. Monika Lehnhardt

Cumulative Survival Percentage, CI24R November 2003

Page 11: CI: Non est miraculum - Dr. Dr. h. c. Monika Lehnhardt

Cumulative Survival Percentage, CI24M November 2003

Page 12: CI: Non est miraculum - Dr. Dr. h. c. Monika Lehnhardt

„Human Failures“

•Medical

•Audiological

•Therapeutic

•Psychological

•Sociological

Page 13: CI: Non est miraculum - Dr. Dr. h. c. Monika Lehnhardt

Selection criteria FDA – Broadening IndicationsDevelopment of candidate selection criteria United States (Nucleus Implant Systems)

12 months and older3-6 months hearing aid trialLack of progress in development of auditory skills or <30% score on MLNT or LNT test, depending on age

Limited benefit from hearing aids defined as 60%or less in best aided condition on tape recorded tests of open-set sentences

2000

18 months and older3-6 months hearing aid trial<20% score on MLNT or LNT test

Limited benefit from hearing aids defined as 40%or less in best aided condition on tape recorded tests of open-set sentences

1998

Include pre-and perilinguistically deafened adults Limited benefit from hearing aids defined as 30%or less in best aided condition on tape recorded tests of open-set sentences

1995

FDA approval for implantation of candidates aged2 years and olderprofound bilateral sensorineuronal deafnesslittle or no benefit from hearing aidcandidate and family must be well motivated and possess realistic expectations

1990

FDA approval for implantation of candidates aged18 years and olderpostlingually deafenedprofound bilateral sensorineuronal deafness no benefit from hearing aid

1985

ChildrenAdults

Page 14: CI: Non est miraculum - Dr. Dr. h. c. Monika Lehnhardt

Neonatal hearing screening – OAE and AABR

Otoacoustic Emissions (OAE)

Automated Auditory Brainstem Response (AABR)

Page 15: CI: Non est miraculum - Dr. Dr. h. c. Monika Lehnhardt

Cost effectiveness

Poorvalueformoney

Goodvalue

formoney

CI beforeage 4

0 1 2 3 4 5 6

Cos

t (€)

0

20000

40000

60000

80000

100000

CI betweenages 4 and 6

QALYs gained0 1 2 3 4 5 6

CI afterage 6

0 1 2 3 4 5 6

73 yrs 73 yrs 73 yrs

15 yrs 15 yrs 15 yrs

Page 16: CI: Non est miraculum - Dr. Dr. h. c. Monika Lehnhardt

Soft Surgery

Page 17: CI: Non est miraculum - Dr. Dr. h. c. Monika Lehnhardt

CT and MRI picture of the Cochlea

Image Source: Courtesy of the University of Melbourne

Page 18: CI: Non est miraculum - Dr. Dr. h. c. Monika Lehnhardt

Programming session with a child

Page 19: CI: Non est miraculum - Dr. Dr. h. c. Monika Lehnhardt

Programming session with a child and parent

Page 20: CI: Non est miraculum - Dr. Dr. h. c. Monika Lehnhardt

Auditory-Verbal Philosophy

Auditory-Verbal International, Inc. Position Statement

• The Auditory-Verbal philosophy is a logical and critical set of guiding principles. These principles outline the essential requirements needed to realize the expectation that young children who are deaf or hard of hearing can be educated to use even minimal amounts of amplified residual hearing.

Use of amplified residual hearing in turn permits children who are deaf or hard of hearing to learn to listen, process verbal language, and to speak.

Page 21: CI: Non est miraculum - Dr. Dr. h. c. Monika Lehnhardt

Auditory-Verbal Principles 1 – 5

1. Early detection and diagnosis

2. Aggressive audiological management

3. Appropriate amplification technology to achieve maximum benefits of learning through listening

4. Favourable auditory learning environments for the acquisition of spoken language including individualized therapy

5. Integrating listening into the child’s entire being so listening becomes a way of life

Page 22: CI: Non est miraculum - Dr. Dr. h. c. Monika Lehnhardt

Auditory-Verbal Principles 6 – 10 6. Ongoing assessment, evaluation and prognosis of the

development of audition, speech, language and cognition

7. Integration and mainstreaming of the children who are deaf or hard of hearing into regular education classes to fullest extent possible

8. Active participation of parents in order to improve spoken communication between the child and family members

9. Affirmation of parents as primary models in helping the child learn to listen to his or her own voice, the voice of others and the sounds of the environment

10. Integration of speech, language, audition and cognition in response to the psychological, social and educational needs of the child and family

Page 23: CI: Non est miraculum - Dr. Dr. h. c. Monika Lehnhardt

Parents with Child

Page 24: CI: Non est miraculum - Dr. Dr. h. c. Monika Lehnhardt

Cochlear Implant – a Miracle?


Recommended